In 2023, government expenditure on R&D in medical and health sciences in Germany was estimated at 3.4 billion USD PPP. The forecast for 2024 to 2028 shows a robust upward trend with values increasing from 3.72 to 5.1 billion USD PPP. Year-on-year variations exhibit steady growth, with an average CAGR of 8.2% expected from 2024 to 2028, indicating strong governmental commitment to advancing medical and health sciences.
Future trends to watch for:
- Policy changes influencing R&D prioritization and investment in emerging health technologies.
- The impact of economic fluctuations on R&D budget allocations.
- Collaborations with international research institutions for innovation.
